| 432 | Humans (MeSH) |
| 180 | Female (MeSH) |
| 154 | Male (MeSH) |
| 109 | Animals (MeSH) |
| 109 | Adult (MeSH) |
| 91 | Middle Aged (MeSH) |
| 59 | Tunisia (MeSH) |
| 59 | Aged (MeSH) |
| 56 | Young Adult (MeSH) |
| 52 | Phylogeny (MeSH) |
| 52 | Molecular Sequence Data (MeSH) |
| 51 | Adolescent (MeSH) |
| 50 | Morocco (MeSH) |
| 47 | Algorithms (MeSH) |
| 45 | Amino Acid Sequence (MeSH) |
| 44 | Databases, Factual (MeSH) |
| 44 | Child (MeSH) |
| 35 | Sequence Analysis, DNA (MeSH) |
| 33 | Tunisia (epidemiology) |
| 30 | Retrospective Studies (MeSH) |
| 29 | Child, Preschool (MeSH) |
| 29 | Base Sequence (MeSH) |
| 28 | Infant (MeSH) |
| 28 | Genotype (MeSH) |
| 28 | Aged, 80 and over (MeSH) |
| 27 | Treatment Outcome (MeSH) |
| 27 | Prevalence (MeSH) |
| 26 | Genetic Variation (MeSH) |
| 25 | Polymerase Chain Reaction (MeSH) |
| 24 | Gene Library (MeSH) |
| 23 | Reproducibility of Results (MeSH) |
| 21 | Risk Factors (MeSH) |
| 19 | Infant, Newborn (MeSH) |
| 19 | Gene Frequency (MeSH) |
| 19 | Bibliometrics (MeSH) |
| 18 | Signal Processing, Computer-Assisted (MeSH) |
| 17 | Pregnancy (MeSH) |
| 17 | Cross-Sectional Studies (MeSH) |
| 16 | RNA, Ribosomal, 16S (genetics) |
| 16 | Polymorphism, Genetic (MeSH) |
| 16 | Databases, Genetic (MeSH) |
| 15 | Polymorphism, Single Nucleotide (MeSH) |
| 15 | Morocco (epidemiology) |
| 15 | Mice (MeSH) |
| 15 | Algeria (MeSH) |
| 14 | Time Factors (MeSH) |
| 14 | Morocco (ethnology) |
| 14 | Genetic Predisposition to Disease (MeSH) |
| 14 | Cluster Analysis (MeSH) |
| 13 | Structure-Activity Relationship (MeSH) |
| 13 | Sequence Alignment (MeSH) |
| 13 | Sensitivity and Specificity (MeSH) |
| 13 | Mutation (MeSH) |
| 13 | Models, Molecular (MeSH) |
| 13 | Genetics, Population (MeSH) |
| 13 | Europe (MeSH) |
| 13 | Computational Biology (methods) |
| 12 | Species Specificity (MeSH) |
| 12 | Sequence Homology, Amino Acid (MeSH) |
| 12 | Prospective Studies (MeSH) |
| 12 | Polymorphism, Restriction Fragment Length (MeSH) |
| 12 | Neural Networks, Computer (MeSH) |
| 12 | Computer Simulation (MeSH) |
| 12 | Computational Biology (MeSH) |
| 12 | Cloning, Molecular (MeSH) |
| 12 | Anti-Bacterial Agents (pharmacology) |
| 11 | Software (MeSH) |
| 11 | Molecular Docking Simulation (MeSH) |
| 11 | DNA, Bacterial (genetics) |
| 11 | Biomedical Research (statistics & numerical data) |
| 11 | Biodiversity (MeSH) |
| 10 | Support Vector Machine (MeSH) |
| 10 | Randomized Controlled Trials as Topic (MeSH) |
| 10 | Publishing (statistics & numerical data) |
| 10 | Publications (statistics & numerical data) |
| 10 | Proteomics (MeSH) |
| 10 | Plant Proteins (genetics) |
| 10 | Peptide Library (MeSH) |
| 10 | Mediterranean Region (MeSH) |
| 10 | Incidence (MeSH) |
| 10 | Developing Countries (MeSH) |
| 10 | Case-Control Studies (MeSH) |
| 10 | Bacteria (genetics) |
| 10 | Alleles (MeSH) |
| 10 | Africa, Northern (epidemiology) |
| 9 | Surveys and Questionnaires (MeSH) |
| 9 | Spain (MeSH) |
| 9 | Pattern Recognition, Automated (methods) |
| 9 | Microbial Sensitivity Tests (MeSH) |
| 9 | History, 20th Century (MeSH) |
| 9 | Ecosystem (MeSH) |
| 9 | Diagnosis, Computer-Assisted (methods) |
| 9 | Databases, Factual (statistics & numerical data) |
| 9 | DNA Fingerprinting (MeSH) |
| 9 | Algeria (epidemiology) |
| 8 | Socioeconomic Factors (MeSH) |
| 8 | RNA, Messenger (genetics) |
| 8 | Internet (MeSH) |
| 8 | Global Health (MeSH) |
| 8 | Gene Expression Profiling (MeSH) |
| 8 | Electrocardiography (methods) |
| 8 | Bacteria (isolation & purification) |
| 8 | Bacteria (classification) |
| 7 | Water Microbiology (MeSH) |
| 7 | Turkey (ethnology) |
| 7 | Temperature (MeSH) |
| 7 | Tandem Mass Spectrometry (MeSH) |
| 7 | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization (methods) |
| 7 | Recurrence (MeSH) |
| 7 | Polymorphism, Single Nucleotide (genetics) |
| 7 | Polymerase Chain Reaction (methods) |
| 7 | Peptides (chemistry) |
| 7 | Molecular Epidemiology (MeSH) |
| 7 | Middle East (MeSH) |
| 7 | Medicine, Traditional (MeSH) |
| 7 | MEDLINE (MeSH) |
| 7 | Language (MeSH) |
| 7 | Image Processing, Computer-Assisted (methods) |
| 7 | History, 21st Century (MeSH) |
| 7 | Geography (MeSH) |
| 7 | Genetic Markers (MeSH) |
| 7 | France (MeSH) |
| 7 | Escherichia coli (genetics) |
| 7 | Electrocardiography (MeSH) |
| 7 | Chromosome Mapping (MeSH) |
| 7 | Binding Sites (MeSH) |
| 6 | United States (MeSH) |
| 6 | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization (MeSH) |
| 6 | Soil Microbiology (MeSH) |
| 6 | Small Molecule Libraries (pharmacology) |
| 6 | Sex Factors (MeSH) |
| 6 | Registries (MeSH) |
| 6 | Reference Values (MeSH) |
| 6 | RNA, Messenger (metabolism) |
| 6 | PubMed (MeSH) |
| 6 | Protein Structure, Tertiary (MeSH) |
| 6 | Prognosis (MeSH) |
| 6 | Phytotherapy (MeSH) |
| 6 | Phylogeography (MeSH) |
| 6 | Pedigree (MeSH) |
| 6 | Netherlands (MeSH) |
| 6 | Mycobacterium tuberculosis (genetics) |
| 6 | Molecular Structure (MeSH) |
| 6 | Models, Theoretical (MeSH) |
| 6 | Models, Statistical (MeSH) |
| 6 | Middle East (epidemiology) |
| 6 | Microsatellite Repeats (MeSH) |
| 6 | MEDLINE (statistics & numerical data) |
| 6 | Logistic Models (MeSH) |
| 6 | Leishmaniasis, Cutaneous (parasitology) |
| 6 | Italy (MeSH) |
| 6 | Image Interpretation, Computer-Assisted (methods) |
| 6 | Haplotypes (MeSH) |
| 6 | Genome-Wide Association Study (MeSH) |
| 6 | Fuzzy Logic (MeSH) |
| 6 | Ethnic Groups (genetics) |
| 6 | DNA, Mitochondrial (genetics) |
| 6 | DNA, Bacterial (chemistry) |
| 6 | Cell Proliferation (drug effects) |
| 6 | Breast Neoplasms (diagnostic imaging) |
| 6 | Blotting, Southern (MeSH) |
| 6 | Arrhythmias, Cardiac (diagnosis) |
| 6 | Antineoplastic Agents (pharmacology) |
| 6 | Age Factors (MeSH) |
| 6 | Africa (MeSH) |
| 5 | Tuberculosis (epidemiology) |
| 5 | Transcriptome (MeSH) |
| 5 | Small Molecule Libraries (chemistry) |
| 5 | Sheep (MeSH) |
| 5 | Seasons (MeSH) |
| 5 | SARS-CoV-2 (MeSH) |
| 5 | Research Design (MeSH) |
| 5 | Quantitative Structure-Activity Relationship (MeSH) |
| 5 | Proteomics (methods) |
| 5 | Protein Binding (MeSH) |
| 5 | Principal Component Analysis (MeSH) |
| 5 | Postoperative Complications (epidemiology) |
| 5 | Plants, Medicinal (classification) |
| 5 | Plant Proteins (metabolism) |
| 5 | Phenotype (MeSH) |
| 5 | Periodicals as Topic (statistics & numerical data) |
| 5 | Parity (MeSH) |
| 5 | Outcome Assessment, Health Care (MeSH) |
| 5 | Neoplasms (epidemiology) |
| 5 | Mutation (genetics) |
| 5 | Molecular Sequence Annotation (MeSH) |
| 5 | Microsatellite Repeats (genetics) |
| 5 | Methicillin-Resistant Staphylococcus aureus (drug effects) |
| 5 | Mammography (methods) |
| 5 | Machine Learning (MeSH) |
| 5 | Longitudinal Studies (MeSH) |
| 5 | Length of Stay (statistics & numerical data) |
| 5 | Islam (MeSH) |
| 5 | Hypertension (epidemiology) |
| 5 | Hydrolysis (MeSH) |
| 5 | Hot Temperature (MeSH) |
| 5 | Hospitalization (statistics & numerical data) |
| 5 | Genome, Plant (genetics) |
| 5 | Genome, Human (MeSH) |
| 5 | Ethnobotany (MeSH) |
| 5 | Emigrants and Immigrants (statistics & numerical data) |
| 5 | Drug Resistance, Bacterial (genetics) |
| 5 | Dose-Response Relationship, Drug (MeSH) |
| 5 | Dogs (MeSH) |
| 5 | Delivery of Health Care (organization & administration) |
| 5 | Databases, Nucleic Acid (MeSH) |
| 5 | DNA, Fungal (genetics) |
| 5 | DNA, Complementary (genetics) |
| 5 | DNA Mutational Analysis (MeSH) |
| 5 | Climate (MeSH) |
| 5 | Cattle (MeSH) |
| 5 | Breast Neoplasms (genetics) |
| 5 | Bayes Theorem (MeSH) |
| 5 | Bacterial Typing Techniques (MeSH) |
| 5 | Bacterial Proteins (metabolism) |
| 5 | Artificial Intelligence (MeSH) |
| 5 | Antineoplastic Agents (chemistry) |
| 5 | Anti-Bacterial Agents (chemistry) |
| 5 | Age Distribution (MeSH) |
| 5 | Africa, Northern (MeSH) |
| 5 | Africa (epidemiology) |
| 4 | World Health Organization (MeSH) |
| 4 | Wavelet Analysis (MeSH) |
| 4 | Water (MeSH) |
| 4 | Ventricular Premature Complexes (diagnosis) |
| 4 | Tumor Suppressor Protein p53 (genetics) |
| 4 | Tuberculosis (microbiology) |
| 4 | Systematic Reviews as Topic (MeSH) |
| 4 | Survival Analysis (MeSH) |
| 4 | Surgical Wound Infection (epidemiology) |
| 4 | Sex Distribution (MeSH) |
| 4 | Severity of Illness Index (MeSH) |
| 4 | Serogroup (MeSH) |
| 4 | Sequence Homology, Nucleic Acid (MeSH) |
| 4 | Sequence Homology (MeSH) |
| 4 | Remission Induction (MeSH) |
| 4 | Regression Analysis (MeSH) |
| 4 | RNA, Viral (genetics) |
| 4 | Public Health (MeSH) |
| 4 | Protein Conformation (MeSH) |
| 4 | Plant Extracts (pharmacology) |
| 4 | Peptides (pharmacology) |
| 4 | Peptides (metabolism) |
| 4 | Odds Ratio (MeSH) |
| 4 | Nucleic Acid Hybridization (MeSH) |
| 4 | Mycobacterium tuberculosis (classification) |
| 4 | Mutation, Missense (MeSH) |
| 4 | Multivariate Analysis (MeSH) |
| 4 | Molecular Dynamics Simulation (MeSH) |
| 4 | Mice, Inbred C57BL (MeSH) |
| 4 | Mice, Inbred BALB C (MeSH) |
| 4 | Macrophages (metabolism) |
| 4 | Leishmania major (physiology) |
| 4 | Journal Impact Factor (MeSH) |
| 4 | Introns (MeSH) |
| 4 | International Cooperation (MeSH) |
| 4 | Insect Proteins (genetics) |
| 4 | Infant Mortality (MeSH) |
| 4 | Hypoglycemic Agents (therapeutic use) |
| 4 | Hospitals (MeSH) |
| 4 | Global Health (statistics & numerical data) |
| 4 | Genomics (MeSH) |
| 4 | Genomic Library (MeSH) |
| 4 | Genes, rRNA (MeSH) |
| 4 | Genes, Plant (MeSH) |
| 4 | Gene Regulatory Networks (MeSH) |
| 4 | Gene Expression Regulation, Enzymologic (MeSH) |
| 4 | Gene Expression Regulation (MeSH) |
| 4 | Ethnopharmacology (MeSH) |
| 4 | Ethnic Groups (MeSH) |
| 4 | Enzyme Inhibitors (pharmacology) |
| 4 | Environmental Monitoring (methods) |
| 4 | Electrophoresis, Polyacrylamide Gel (MeSH) |
| 4 | Electron Transport Complex IV (genetics) |
| 4 | Drug Screening Assays, Antitumor (MeSH) |
| 4 | Disease Progression (MeSH) |
| 4 | Discriminant Analysis (MeSH) |
| 4 | Diet (MeSH) |
| 4 | Databases, Protein (MeSH) |
| 4 | Database Management Systems (MeSH) |
| 4 | DNA-Binding Proteins (genetics) |
| 4 | DNA, Plant (genetics) |
| 4 | DNA, Complementary (MeSH) |
| 4 | DNA Barcoding, Taxonomic (MeSH) |
| 4 | Cross Infection (epidemiology) |
| 4 | Consanguinity (MeSH) |
| 4 | China (MeSH) |
| 4 | Chi-Square Distribution (MeSH) |
| 4 | Cell Line, Tumor (MeSH) |
| 4 | Camelus (MeSH) |
| 4 | COVID-19 (MeSH) |
| 4 | Breast Neoplasms (metabolism) |
| 4 | Breast Neoplasms (diagnosis) |
| 4 | Body Mass Index (MeSH) |
| 4 | Bluetongue virus (genetics) |
| 4 | Bluetongue (virology) |
| 4 | Blood Pressure (MeSH) |
| 4 | Biomedical Research (organization & administration) |
| 4 | Biomedical Research (history) |
| 4 | Bias (MeSH) |
| 4 | Bacterial Typing Techniques (methods) |
| 4 | Asia (MeSH) |
| 4 | Archaea (isolation & purification) |
| 4 | Archaea (genetics) |
| 4 | Archaea (classification) |
| 4 | Arabs (genetics) |
| 4 | Arab World (MeSH) |
| 4 | Antineoplastic Agents (therapeutic use) |
| 4 | Animal Distribution (MeSH) |
| 4 | Abstracting and Indexing (MeSH) |
| 3 | Whole Genome Sequencing (MeSH) |
| 3 | Water Pollutants, Chemical (analysis) |
| 3 | Water (chemistry) |
| 3 | Viper Venoms (chemistry) |
| 3 | Vaccination (MeSH) |
| 3 | User-Computer Interface (MeSH) |
| 3 | Urinary Bladder, Overactive (drug therapy) |
| 3 | United Kingdom (MeSH) |
| 3 | Triticum (metabolism) |
| 3 | Triticum (genetics) |
| 3 | Transcription Factors (metabolism) |
| 3 | Suriname (ethnology) |
| 3 | Sudan (MeSH) |
| 3 | Stress, Physiological (MeSH) |
| 3 | Staphylococcus aureus (drug effects) |
| 3 | Spectroscopy, Fourier Transform Infrared (MeSH) |
| 3 | Serotyping (MeSH) |
| 3 | Scorpion Venoms (chemistry) |
| 3 | Saudi Arabia (MeSH) |
| 3 | Rodentia (MeSH) |
| 3 | Risk Assessment (MeSH) |
| 3 | Risk (MeSH) |
| 3 | Reverse Transcriptase Polymerase Chain Reaction (MeSH) |
| 3 | Refuse Disposal (methods) |
| 3 | Recombinant Fusion Proteins (genetics) |
| 3 | Rats (MeSH) |
| 3 | Radiographic Image Interpretation, Computer-Assisted (methods) |
| 3 | Rabies virus (immunology) |
| 3 | Quality-Adjusted Life Years (MeSH) |
| 3 | Proteome (analysis) |
| 3 | Proteome (MeSH) |
| 3 | Proteins (chemistry) |
| 3 | Protein Kinase Inhibitors (pharmacology) |
| 3 | Protein Kinase Inhibitors (chemistry) |
| 3 | Proportional Hazards Models (MeSH) |
| 3 | Postoperative Complications (MeSH) |
| 3 | Population Dynamics (MeSH) |
| 3 | Polymorphism, Genetic (genetics) |
| 3 | Plants, Medicinal (chemistry) |
| 3 | Plant Proteins (chemistry) |
| 3 | Plant Proteins (analysis) |
| 3 | Plant Leaves (genetics) |
| 3 | Plant Extracts (chemistry) |
| 3 | Plant Extracts (adverse effects) |
| 3 | Phlebotomus (genetics) |
| 3 | Periodicals as Topic (MeSH) |
| 3 | Peptides (genetics) |
| 3 | Pattern Recognition, Automated (MeSH) |
| 3 | Pandemics (MeSH) |
| 3 | Osteoporosis (diagnostic imaging) |
| 3 | Operative Time (MeSH) |
| 3 | Open Reading Frames (MeSH) |
| 3 | Olive Oil (MeSH) |
| 3 | Netherlands (epidemiology) |
| 3 | Neoplasms (drug therapy) |
| 3 | Mycobacterium tuberculosis (isolation & purification) |
| 3 | Mycobacterium tuberculosis (drug effects) |
| 3 | Mutation, Missense (genetics) |
| 3 | Multilocus Sequence Typing (MeSH) |
| 3 | Mortality (trends) |
| 3 | Mortality (MeSH) |
| 3 | Morbidity (trends) |
| 3 | Morbidity (MeSH) |
| 3 | Microscopy, Electron, Scanning (MeSH) |
| 3 | Mental Disorders (epidemiology) |
| 3 | Melanoma (pathology) |
| 3 | Mass Spectrometry (MeSH) |
| 3 | Macrophages (parasitology) |
| 3 | Linkage Disequilibrium (MeSH) |
| 3 | Leishmaniasis, Cutaneous (epidemiology) |
| 3 | Leishmania (genetics) |
| 3 | Leishmania (classification) |
| 3 | Lebanon (MeSH) |
| 3 | Larva (chemistry) |
| 3 | Kaplan-Meier Estimate (MeSH) |
| 3 | Jews (genetics) |
| 3 | Italy (epidemiology) |
| 3 | Insect Vectors (MeSH) |
| 3 | Insect Proteins (chemistry) |
| 3 | Information Storage and Retrieval (methods) |
| 3 | Infant, Low Birth Weight (MeSH) |
| 3 | India (MeSH) |
| 3 | Income (MeSH) |
| 3 | Immunoglobulin E (immunology) |
| 3 | Image Processing, Computer-Assisted (MeSH) |
| 3 | Hypertension (diagnosis) |
| 3 | Hydrogen-Ion Concentration (MeSH) |
| 3 | History, Ancient (MeSH) |
| 3 | High-Throughput Screening Assays (MeSH) |
| 3 | Hematopoietic Stem Cell Transplantation (MeSH) |
| 3 | Heart Rate (MeSH) |
| 3 | Health Surveys (MeSH) |
| 3 | HIV Infections (epidemiology) |
| 3 | Gestational Age (MeSH) |
| 3 | Geologic Sediments (microbiology) |
| 3 | Genetic Markers (genetics) |
| 3 | Genetic Association Studies (MeSH) |
| 3 | Genes, Recessive (genetics) |
| 3 | Gene Expression Profiling (methods) |
| 3 | Gene Expression (MeSH) |
| 3 | Fungal Proteins (genetics) |
| 3 | Food Microbiology (MeSH) |
| 3 | Follow-Up Studies (MeSH) |
| 3 | Fasting (MeSH) |
| 3 | Facial Recognition (MeSH) |
| 3 | Expressed Sequence Tags (MeSH) |
| 3 | Evolution, Molecular (MeSH) |
| 3 | Europe (epidemiology) |
| 3 | Escherichia coli (drug effects) |
| 3 | Epitopes (immunology) |
| 3 | Epitope Mapping (MeSH) |
| 3 | Epilepsy (drug therapy) |
| 3 | Enzyme-Linked Immunosorbent Assay (MeSH) |
| 3 | Enzyme Inhibitors (chemistry) |
| 3 | Emigrants and Immigrants (MeSH) |
| 3 | Electrophoresis, Gel, Two-Dimensional (MeSH) |
| 3 | Drug Prescriptions (statistics & numerical data) |
| 3 | Disease Outbreaks (MeSH) |
| 3 | Diabetes Mellitus, Type 2 (drug therapy) |
| 3 | Data Mining (MeSH) |
| 3 | Data Interpretation, Statistical (MeSH) |
| 3 | DNA, Bacterial (isolation & purification) |
| 3 | DNA, Bacterial (analysis) |
| 3 | DNA, Archaeal (genetics) |
| 3 | DNA Repair (MeSH) |
| 3 | DNA Primers (genetics) |
| 3 | DNA Primers (MeSH) |
| 3 | DNA (genetics) |
| 3 | DNA (chemistry) |
| 3 | Cross Infection (microbiology) |
| 3 | Costs and Cost Analysis (MeSH) |
| 3 | Continental Population Groups (genetics) |
| 3 | Computer Security (MeSH) |
| 3 | Comorbidity (MeSH) |
| 3 | Cloning, Molecular (methods) |
| 3 | Clinical Trials as Topic (MeSH) |
| 3 | Cities (MeSH) |
| 3 | Chromatography, Liquid (MeSH) |
| 3 | Chromatography, High Pressure Liquid (MeSH) |
| 3 | Cells, Cultured (MeSH) |
| 3 | Cell Survival (drug effects) |
| 3 | Cell Line (MeSH) |
| 3 | Capsid Proteins (genetics) |
| 3 | Breast Neoplasms (pathology) |
| 3 | Breast (diagnostic imaging) |
| 3 | Brazil (MeSH) |
| 3 | Body Height (MeSH) |
| 3 | Bluetongue (epidemiology) |
| 3 | Blotting, Northern (MeSH) |
| 3 | Biomedical Research (trends) |
| 3 | Biomedical Research (MeSH) |
| 3 | Biomarkers (blood) |
| 3 | Bibliometrics (history) |
| 3 | Benzodiazepines (therapeutic use) |
| 3 | Bacterial Proteins (genetics) |
| 3 | Bacterial Proteins (chemistry) |
| 3 | Bacteria (metabolism) |
| 3 | Avena (enzymology) |
| 3 | Asthenozoospermia (genetics) |
| 3 | Arrhythmias, Cardiac (physiopathology) |
| 3 | Antioxidants (pharmacology) |
| 3 | Antifungal Agents (pharmacology) |
| 3 | Antibodies, Viral (immunology) |
| 3 | Anti-Infective Agents (pharmacology) |
| 3 | Analysis of Variance (MeSH) |
| 3 | Amino Acid Substitution (MeSH) |
| 3 | Amino Acid Motifs (MeSH) |
| 3 | African Continental Ancestry Group (genetics) |
| 3 | Acute Disease (MeSH) |
| 2 | beta-Lactamases (genetics) |
| 2 | beta-Amylase (chemistry) |
| 2 | Xeroderma Pigmentosum Group D Protein (genetics) |
| 2 | Workload (statistics & numerical data) |
| 2 | Workflow (MeSH) |
| 2 | Web Browser (MeSH) |
| 2 | Waste Water (microbiology) |
| 2 | Vitis (genetics) |
| 2 | Viral Vaccines (genetics) |
| 2 | Viral Proteins (genetics) |
| 2 | Viral Envelope Proteins (genetics) |
| 2 | Viper Venoms (enzymology) |
| 2 | Urinary Bladder Neoplasms (genetics) |
| 2 | Urban Population (statistics & numerical data) |
| 2 | Universal Health Insurance (economics) |
| 2 | Type C Phospholipases (genetics) |
| 2 | Turkeys (MeSH) |
| 2 | Tumor Suppressor Protein p53 (metabolism) |
| 2 | Tumor Cells, Cultured (MeSH) |
| 2 | Transferases (Other Substituted Phosphate Groups) (genetics) |
| 2 | Transcription, Genetic (MeSH) |
